anal cancer
Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?
By Emily Morton-West
A Call to Action: Bridging the Adult Immunization Divide
Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...
Sanofi and Kling Bio partner to accelerate discovery of neutralising antibodies
The alliance will centre on Kling’s B cell immortalisation and screening platform Kling-Select
Video: Strategic engagement case study
Supporting the launch of a global vaccine with a programme of market research and strategic insights
WHO launches R&D efforts to identify pathogens that could cause future pandemics
Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’
CDC shows new BQ.1 and BQ 1.1 Omicron subvariants account for 44% of US COVID-19 cases
The two new variants accounted for over 32% of US cases the prior week
Global leaders pledge $2.6bn at World Health Summit in efforts to end polio
The pledging moment was a milestone in fulfilling the $4.8bn required to implement the GPEI Strategy
ONS data reveals significant decrease in COVID-19 antibodies
The latest figures have prompted calls for the government to start its autumn booster vaccination campaigns as soon as possible
Moderna secures £1.74bn deal to supply US government with updated COVID-19 vaccine
The company will supply 66 million doses of its COVID-19 vaccine booster updated for the Omicron subvariant
Mix-and-match COVID-19 vaccines may be more effective
A small study shows a booster shot of J&J’s vaccine six months after a primary course of the Pfizer/BioNTech vaccine may offer more protection
Annual COVID-19 jabs likely, says Pfizer head
Pfizer CEO predicts annual jabs will be needed to maintain a ‘very high level of protection’ against COVID-19 and emphasises the need to vaccinate children
COVID-19 vaccines against Omicron may be fast-tracked
Regulators including the Food and Drug Administration (FDA) may treat Omicron-specific mRNA vaccines like seasonal flu vaccines, speeding up approval